ZOLL Medical, a company that manufactures medical devices and related software, announced that it has completed its acquisition of Itamar Medical, a medical device and digital health company that provides at-home testing for sleep apnea.
“We are pleased to announce the closing of the acquisition of Itamar and welcome its employees to the ZOLL family,” says Jon Rennert, ZOLL CEO, in a statement. “Together, ZOLL and Itamar Medical will help more patients receive diagnosis and treatment for sleep-disordered breathing and help strengthen the collaboration between the worlds of cardiology and sleep medicine.”
Itamar Medical will operate as a business division within ZOLL, and Gilad Glick, who previously served as Itamar Medical’s CEO, will lead the division as its president. Itamar Medical’s principal operations in Caesarea, Israel will continue with no material changes to operations currently anticipated.
Moving forward, ZOLL will focus on the continuity of Itamar Medical’s business while using ZOLL’s global infrastructure and brand to accelerate and expand growth opportunities.